Sandoz Canada Inc., a prominent subsidiary of the global healthcare leader Novartis, is headquartered in Canada and operates extensively across the country. Founded in 1886, Sandoz has established itself as a key player in the pharmaceutical industry, specialising in generic and biosimilar medicines. The company is renowned for its commitment to high-quality, affordable healthcare solutions, offering a diverse portfolio that includes injectable medications, oral therapies, and complex generics. With a strong focus on innovation, Sandoz Canada has achieved significant milestones, including the launch of several groundbreaking biosimilars that enhance patient access to essential treatments. As a leader in the Canadian market, Sandoz is dedicated to improving patient outcomes while maintaining a robust pipeline of products that address unmet medical needs.
How does Sandoz Canada Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sandoz Canada Inc.'s score of 68 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sandoz Canada Inc., headquartered in Canada, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Sandoz Group AG, which may influence its climate commitments and performance metrics. While Sandoz Canada Inc. has not outlined specific reduction targets or achievements, it is important to note that its climate initiatives and commitments are likely aligned with those of its parent company, Sandoz Group AG. This includes adherence to industry standards and practices in managing carbon emissions, although specific details on reduction initiatives or targets have not been disclosed. As a subsidiary, Sandoz Canada Inc. may benefit from the broader sustainability strategies and frameworks established by Sandoz Group AG, which could include participation in initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). However, without specific data or commitments from Sandoz Canada Inc. itself, a detailed assessment of its carbon footprint and climate strategy remains unavailable.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 75,620,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 158,430,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 0,000,000,000 | 0,000,000,000 |
Sandoz Canada Inc.'s Scope 3 emissions, which decreased by 15% last year and decreased by approximately 15% since 2023, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 69% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sandoz Canada Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.